{"gene":"GUCA1A","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1998,"finding":"GCAP1 Y99C mutation causes constitutive activation of retinal guanylyl cyclase (RetGC): recombinant Y99C GCAP1 fails to inhibit RetGC even at Ca2+ concentrations above 1 µM, rendering the cyclase constitutively active across the entire physiological Ca2+ range.","method":"In vitro reconstitution assay of RetGC activity with recombinant Y99C GCAP1 at varying free Ca2+ concentrations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with recombinant mutant protein; independently replicated in same year by Sokal et al. (PMID:9702199)","pmids":["9651312","9702199"],"is_preprint":false},{"year":1998,"finding":"GCAP1 (Y99C) mutant is constitutively active: it persistently stimulates GC1 under physiological dark conditions due to markedly altered Ca2+ sensitivity, consistent with elevated cGMP in dark-adapted cones.","method":"In vitro GC1 stimulation assay and Ca2+-dependent activity measurements with recombinant GCAP1(Y99C)","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution, replicated across two independent labs","pmids":["9702199"],"is_preprint":false},{"year":1994,"finding":"Human GCAP1 (GUCA1A) is a Ca2+-binding protein with three EF-hand motifs expressed exclusively in photoreceptor inner segments, encoded by a four-exon gene localized to chromosome 6p21.1, and stimulates cGMP synthesis.","method":"Molecular cloning, in situ hybridization, genomic mapping by somatic hybrid panel and FISH, in vitro cGMP synthesis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods in foundational study; replicated widely","pmids":["7983048"],"is_preprint":false},{"year":2006,"finding":"The Mg2+-bound form of GCAP1 (not the cation-free form) is the true physiological activator of RetGC1 in light-adapted photoreceptors; Mg2+ binding in EF-hands 2 and 3 is essential for RetGC1 stimulation.","method":"In vitro RetGC1 activation assay at physiological Mg2+/Ca2+ concentrations; tryptophan fluorescence to monitor conformational states; EF-hand mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution + mutagenesis + fluorescence spectroscopy in single rigorous study","pmids":["16793776"],"is_preprint":false},{"year":2007,"finding":"Mg2+ binding in EF-hand 2 of GCAP1 increases its affinity for RetGC ~40-fold and is essential for cyclase activation; Mg2+ binding in EF-hand 3 enhances stimulation 2-fold; Ca2+ binding in EF-hand 4 triggers the activator-to-inhibitor switch, while EF-hand 3 modulates Ca2+-dependent deceleration indirectly through EF-hand 4.","method":"In vitro RetGC1 activation assays with EF-hand mutants; tryptophan fluorescence; Mg2+/Ca2+ competition measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis of all four EF-hands combined with in vitro reconstitution","pmids":["17545152"],"is_preprint":false},{"year":2001,"finding":"GCAP1 E155G mutation (in EF4 domain) eliminates Ca2+ binding via loss of bidentate coordination, causing constitutive activation of RetGC at high Ca2+ concentrations and autosomal dominant cone dystrophy.","method":"In vitro RetGC activation assay with recombinant E155G GCAP1; structural modeling","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, structural modeling; replicated in later studies","pmids":["11484154"],"is_preprint":false},{"year":1999,"finding":"Two short regions (M445–L456 and L503–I522) in the juxtamembrane domain (JMD) of ROS-GC1 are critical for GCAP1-dependent activation, identified by peptide competition and mutagenesis.","method":"Peptide competition assays and mutagenesis of ROS-GC1 expressed in cells; in vitro cyclase activity measurements","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis and competition assays define functional domains","pmids":["10571055"],"is_preprint":false},{"year":2008,"finding":"Metal binding in EF-hand 2 of GCAP1 is crucial for its binding to RetGC1; EF-hand 3 enhances but is not essential for association; EF-hand 4 mediates only the activator-to-inhibitor switch and is not required for primary cyclase attachment.","method":"Co-localization and co-transfection in HEK293 cells with GFP-tagged GCAP1 EF-hand mutants and mOrange-tagged RetGC1; live-cell fluorescence imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — cell-based co-localization with systematic EF-hand mutagenesis; consistent with in vitro data from same lab","pmids":["18541533"],"is_preprint":false},{"year":2010,"finding":"RetGC1 binds GCAP1 in an equimolar (1:1) stoichiometry in HEK293 cells; mutations D639Y and R768W in the kinase homology domain of RetGC1 abolish GCAP1 binding and activation, implicating this domain in GCAP1 recognition.","method":"FRET-based stoichiometry measurement of fluorescently labeled RetGC1 and GCAP1 co-expressed in HEK293 cells; in vitro reconstitution assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — quantitative stoichiometry in cyto combined with mutagenesis and in vitro activity assay","pmids":["20050595"],"is_preprint":false},{"year":2014,"finding":"The RetGC1 binding site on GCAP1 is a distinct surface patch formed by EF-hand 1, the loop and exiting helix of EF-hand 2, and the entering helix of EF-hand 3; residues Met-26, Lys-85, and Trp-94 are required for cyclase activation (an additional step beyond binding).","method":"Systematic surface mutagenesis of GCAP1; co-localization and RetGC1 activation assays in HEK293 cells; in vitro RetGC1 stimulation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — comprehensive surface mutagenesis combined with cell-based and in vitro functional assays","pmids":["24567338"],"is_preprint":false},{"year":2015,"finding":"The dimerization domain of RetGC1, especially residues Arg-822 and Met-823, is an essential part of the GCAP1/2 binding interface; disruption at this site (R822P, disease mutation) abolishes GCAP binding but not RD3 binding or cyclase dimerization.","method":"RetGC1/NPRA chimera construction; co-expression and co-localization assay in HEK293 cells with GFP-tagged GCAP1; in vitro RetGC1 activation assay; functional complementation tests","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — systematic domain-swap mutagenesis with cell-based and in vitro functional validation","pmids":["26100624"],"is_preprint":false},{"year":2015,"finding":"NMR structure of GCAP1(V77E) in Ca2+-free/Mg2+-bound activator state reveals that Mg2+ binds at EF2; Ca2+-dependent structural changes occur specifically in the EF4 Ca2+-switch helix (residues 164–174); deletion or mutation of this helix abolishes RetGC1 activation and reduces Ca2+ binding affinity.","method":"NMR spectroscopy with residual dipolar coupling; in vitro RetGC1 activation assays; Ca2+ binding analysis of helix deletion mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure combined with functional mutagenesis validation","pmids":["26703466"],"is_preprint":false},{"year":2002,"finding":"GCAP1 alone (in the absence of GCAP2) is sufficient to support wild-type flash responses and recovery kinetics in rod photoreceptors in vivo.","method":"Transgenic rescue experiment: GCAP1 expressed under endogenous promoter in GCAP1/GCAP2 double-knockout mice; paired-flash ERG recordings; single-cell recordings","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — transgenic rescue with electrophysiological functional readout, replicated in subsequent study","pmids":["11927539"],"is_preprint":false},{"year":2003,"finding":"GCAP1 is required for normal cone photoreceptor response recovery; GCAP1/GCAP2 double-knockout mice show delayed cone a-wave and b-wave recovery, and transgenic GCAP1 restores normal cone recovery.","method":"ERG recordings (photopic, paired-flash) in GCAP null and GCAP1 transgenic rescue mice; immunohistochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue with defined electrophysiological phenotype, replicated across labs","pmids":["12732716"],"is_preprint":false},{"year":2001,"finding":"GCAP1 P50L mutation reduces protein stability (increased protease susceptibility, reduced thermal stability) without altering Ca2+ sensitivity or RetGC1 activation, suggesting haploinsufficiency via reduced protein concentration as the disease mechanism.","method":"In vitro RetGC1 activation assay; circular dichroism spectroscopy; protease resistance assay; thermal stability assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro assays with multiple methods, but single lab study","pmids":["11136713"],"is_preprint":false},{"year":2004,"finding":"GCAP1 I143NT mutation (in EF4) partially inhibits GC at high Ca2+, adopts a protease-susceptible conformation, and results in incomplete inactivation consistent with constitutive GC activation in dark-adapted cones.","method":"In vitro RetGC stimulation assay; fluorescence emission spectra; limited proteolysis; immunoblotting","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 1 — multiple biochemical methods, single lab","pmids":["15505030"],"is_preprint":false},{"year":2009,"finding":"Novel GCAP1 mutations (E89K, D100E, G159V, L151F) alter Ca2+-dependent conformational changes and persistent stimulation of guanylate cyclase at physiological Ca2+ concentrations, while still functioning as Ca2+ sensors.","method":"Purified recombinant GCAP1 variants; Ca2+-triggered conformational change assays; apparent interaction affinity with RetGC; Ca2+-dependent activation profiles","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical characterization of multiple mutants, single lab","pmids":["19459154"],"is_preprint":false},{"year":2010,"finding":"All tested disease-associated GCAP1 variants (Y99C, E155G, P50L, I143NT) show decreased Ca2+ affinity and reduced thermal stability; myristoylation increases Ca2+ affinity and thermal stability; non-myristoylated mutants activate ROS-GC1 at nonphysiological Ca2+ concentrations.","method":"Ca2+ binding measurements; thermal stability assays; ROS-GC1 activation assays; CD spectroscopy","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 1 — multiple biochemical methods, single lab","pmids":["20213926"],"is_preprint":false},{"year":2012,"finding":"N-terminal myristoylation of GCAP1 (Gly2) is required for efficient activation of RetGC1 in vitro; the non-myristoylated G2A mutant co-localizes with RetGC1 less efficiently and shifts Ca2+ sensitivity of the cyclase to higher Ca2+ concentrations.","method":"Co-localization of GFP-tagged G2A GCAP1 with RetGC1 in HEK293 cells; in vitro RetGC1 activation assay; Ca2+ binding isotherm measurement","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based co-localization and in vitro reconstitution, single lab","pmids":["22371697"],"is_preprint":false},{"year":1999,"finding":"Ca2+ binding to GCAP1 causes a major conformational change around the EF3-hand region, transitioning GCAP1 from activator to inhibitor of GC; the Y99C mutation (adjacent to EF3) prevents stabilization of the inactive Ca2+-bound complex; Ca2+ association occurs near diffusion-limit (k1 > 2×10^8 M⁻¹s⁻¹) and dissociation is rapid.","method":"Site-directed Trp mutagenesis; fluorescence spectroscopy; stopped-flow kinetics; in vitro GC activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution + spectroscopy + kinetics + mutagenesis in single study","pmids":["10391927"],"is_preprint":false},{"year":2019,"finding":"GCAP1 G86R mutation (in the hinge connecting EF-hands 2 and 3) strongly impairs Ca2+-dependent activator-to-inhibitor conformational transition, activates RetGC with higher affinity at low Ca2+ but fails to decelerate it at dark-adapted Ca2+ concentrations; the mutation also reduces sensitivity of RD3-mediated inhibition of the GCAP1-RetGC1 complex.","method":"In vitro RetGC1 activation assay; Trp94 fluorescence; isothermal titration calorimetry; dose-response for RD3 inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro methods (ITC, fluorescence, enzyme activity) in single study","pmids":["30622141"],"is_preprint":false},{"year":2011,"finding":"Knock-in mice expressing E155G GCAP1 show progressive cone-dominant photoreceptor degeneration preceded by cGMP accumulation, establishing constitutive guanylate cyclase activation as the disease mechanism in dominant cone-rod dystrophy.","method":"Gene targeting/knock-in mouse model; ERG; retinal histology; immunohistochemistry; cGMP level measurements","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — physiologically relevant knock-in model with multiple functional and molecular readouts","pmids":["21464903"],"is_preprint":false},{"year":2017,"finding":"GCAP1 L176F mutation associated with macular dystrophy causes constitutive activation of guanylate cyclase; the mutant is less sensitive to Ca2+ changes, shows 90-fold higher GC activation than WT (vs 20-fold for WT), binds GC with higher apparent affinity, and binds Mg2+ with higher affinity.","method":"In vitro RetGC activation assay; Ca2+/Mg2+ binding measurements; CD spectroscopy; molecular dynamics simulations","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical characterization with multiple methods, single lab","pmids":["28025326"],"is_preprint":false},{"year":2018,"finding":"GCAP1 E111V mutation disrupts Ca2+ coordination in EF3, reducing Ca2+ affinity ~80-fold; the Mg2+-bound form prone to aggregation; both WT and E111V form dimers; functional assay shows E111V shifts GC inhibition outside physiological Ca2+ range (IC50 ~10 µM), causing constitutive cGMP synthesis.","method":"Heterologous expression and purification; circular dichroism; fluorescence spectroscopy; molecular dynamics simulations; in vitro RetGC1 activation assay; analytical gel filtration","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including structural and functional assays in single study","pmids":["30184081"],"is_preprint":false},{"year":2016,"finding":"Molecular dynamics simulations reveal that Mg2+/Ca2+ exchange in GCAP1 EF-hands routes allosteric communication pathways that selectively switch GC activation/inhibition; myristoylation mediates long-range allosteric interactions including EF2–EF4 coupling and communication between EF4 and the GC binding interface.","method":"Exhaustive molecular dynamics simulations; allosteric pathway analysis","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only, no experimental validation in this study","pmids":["27739433"],"is_preprint":false},{"year":2004,"finding":"In GC1 knockout mice, GCAP1 protein is specifically downregulated and absent from photoreceptor outer segments (while GCAP2 is less affected), and GC1-GCAP1 interactions are essential for cone cell function.","method":"Western blot; Northern blot; immunohistochemistry of GC1 knockout mouse retina","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with protein localization and expression analysis","pmids":["15452041"],"is_preprint":false},{"year":2010,"finding":"GCAP1 is biochemically and physiologically coupled to the olfactory guanylate cyclase ONE-GC in ciliary membranes, where it acts as an incremental stimulator of ONE-GC in response to rising Ca2+ (nanomolar to semi-micromolar range), reversing its inhibitory role in ROS-GC1 phototransduction signaling.","method":"Gene deletion; live-cell FRET; surface plasmon resonance spectroscopy; enzyme activity assays","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — FRET, SPR, and gene deletion with multiple functional readouts, single lab","pmids":["20684533"],"is_preprint":false},{"year":2013,"finding":"NMR analysis of GCAP1 reveals that Ca2+-dependent structural changes are concentrated at EF4 and EF1; residues K23 and G32 in EF1 show large chemical shift differences and their mutation decreases RetGC1 activation, confirming a functional conformational change in EF1.","method":"NMR chemical shift assignments of Ca2+-saturated WT vs EF4mut GCAP1; site-directed mutagenesis; in vitro RetGC1 activation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 — NMR with functional mutagenesis, single study","pmids":["24236217"],"is_preprint":false},{"year":2020,"finding":"GCAPs ablation substantially delays photoreceptor cell death in rd3 mice; Ca2+-free GCAP proteins retained at the inner segment in activator conformation induce endoplasmic reticulum stress and mitochondrial swelling, mediating photoreceptor death in LCA12.","method":"Genetic double-knockout (rd3 × GCAPs-/-) mice; retinal cell counting; ER stress markers; mitochondrial ultrastructure; phosphorylation state of GCAP2","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with defined cellular phenotype and molecular markers, single study","pmids":["31980596"],"is_preprint":false},{"year":2021,"finding":"GCAP1 N104H mutation impairs Ca2+ sensitivity and strongly doubles the affinity for GC (EC50 halved), resulting in constitutive GC hyperactivation; molecular dynamics shows increased flexibility at the GCAP1/GC interface under high Ca2+ conditions.","method":"Heterologous expression; circular dichroism; limited proteolysis; dynamic light scattering; in vitro RetGC1 activation assay; molecular dynamics simulations","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical characterization with multiple methods, single lab","pmids":["34639157"],"is_preprint":false},{"year":2022,"finding":"RetGC1 undergoes a two-state allosteric switch between active (R-state, stabilized by Ca2+-free/Mg2+-bound GCAP1) and inactive (T-state, stabilized by Ca2+-bound GCAP1 or RD3) conformations; exposed hydrophobic residues H19, Y22, M26, F73, V77, W94 in GCAP1 are essential for cyclase activation.","method":"Structural review integrating NMR data, mutagenesis, and modeling","journal":"Frontiers in molecular neuroscience","confidence":"Low","confidence_rationale":"Tier 3 — review/structural synthesis, not primary experimental data","pmids":["36157073"],"is_preprint":false},{"year":2020,"finding":"D100G, E155A, and E155G mutations in GCAP1 EF-hands cause constitutive GC activation; all three variants form stable dimers with decreased Ca2+ affinity; mutation of bidentate glutamate in one EF-hand allosterically destabilizes the adjacent EF-hand, suggesting inter-EF-hand allosteric coupling.","method":"Recombinant protein expression; circular dichroism; fluorescence spectroscopy; in vitro GC activation assay; molecular dynamics simulations","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical characterization with multiple methods, single lab","pmids":["32650103"],"is_preprint":false},{"year":2024,"finding":"Wild-type GCAP1 directly interacts with RD3; the interaction is Ca2+-dependent (Ca2+-bound GCAP1 binds RD3 with KD ~1.6 µM, Mg2+-bound GCAP1 much more weakly); the E111V mutation completely abolishes RD3 binding; RD3 inhibits GC1 through dual mechanisms (direct GC1 binding and GCAP1-mediated inhibition); GCAP1-RD3-GC1 co-localize in photoreceptor inner segments and synaptic terminals.","method":"Surface plasmon resonance; NMR spectroscopy; AlphaFold3 modeling; enzymatic assays; immunohistochemistry; in vitro reconstitution","journal":"International journal of biological macromolecules","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (SPR, NMR, enzyme assays, IHC) in single study with structural validation","pmids":["41819313"],"is_preprint":false}],"current_model":"GCAP1 (encoded by GUCA1A) is a myristoylated neuronal Ca2+/Mg2+ sensor protein expressed in photoreceptor outer segments that serves as the principal feedback regulator of retinal guanylyl cyclase (RetGC1): in light-adapted photoreceptors at low Ca2+, its Mg2+-bound form (EF-hands 2 and 3 occupied by Mg2+) binds RetGC1 through a specific surface patch on EF1/EF2/EF3 and the cyclase dimerization domain to stimulate cGMP synthesis; as Ca2+ rises during dark adaptation, Ca2+ binding to EF-hand 4 (the 'Ca2+-switch helix') triggers an allosteric conformational change that converts GCAP1 into a cyclase inhibitor, with additional inhibition mediated by RD3 binding to Ca2+-loaded GCAP1; disease-causing mutations in EF-hands disrupt Ca2+ sensing and render GCAP1 constitutively active, causing toxic cGMP accumulation and dominant cone/cone-rod dystrophies."},"narrative":{"teleology":[{"year":1994,"claim":"Identification of GCAP1 as a photoreceptor-specific Ca²⁺-binding protein that stimulates cGMP synthesis established the molecular identity of the guanylyl cyclase activating protein in the phototransduction cascade.","evidence":"Molecular cloning, in situ hybridization, genomic mapping, and in vitro cGMP synthesis assay","pmids":["7983048"],"confidence":"High","gaps":["Mechanism of Ca²⁺-dependent regulation not yet defined","Target cyclase identity not confirmed in vivo","Role of individual EF-hands unknown"]},{"year":1998,"claim":"Demonstrating that the Y99C disease mutation renders GCAP1 constitutively active across the full Ca²⁺ range linked a specific molecular defect—loss of Ca²⁺-dependent inhibition—to dominant cone dystrophy and established the activator-to-inhibitor switch as essential for photoreceptor health.","evidence":"In vitro RetGC reconstitution assays with recombinant Y99C GCAP1 at varying Ca²⁺, replicated independently by two labs","pmids":["9651312","9702199"],"confidence":"High","gaps":["Structural basis of Y99C effect unknown","In vivo consequences not yet demonstrated in animal model"]},{"year":1999,"claim":"Fluorescence and kinetic analyses revealed that Ca²⁺ binding triggers a major conformational change near EF3, transitioning GCAP1 from activator to inhibitor, and that the Y99C mutation prevents this transition—establishing the conformational switch mechanism.","evidence":"Site-directed Trp mutagenesis, fluorescence spectroscopy, stopped-flow kinetics, and in vitro GC assays","pmids":["10391927"],"confidence":"High","gaps":["Atomic-resolution structure of activator vs inhibitor states not available","Role of Mg²⁺ not yet appreciated"]},{"year":1999,"claim":"Mapping two short regions in the RetGC1 juxtamembrane domain as critical for GCAP1-dependent activation began defining the cyclase-side binding interface.","evidence":"Peptide competition and mutagenesis of ROS-GC1 with in vitro cyclase activity readout","pmids":["10571055"],"confidence":"High","gaps":["Full binding interface on both partners undefined","Stoichiometry unknown"]},{"year":2001,"claim":"Characterization of P50L (haploinsufficiency via protein instability) and E155G (constitutive activation via loss of EF4 Ca²⁺ coordination) established that distinct molecular mechanisms—both affecting Ca²⁺-dependent regulation—underlie different GCAP1 disease alleles.","evidence":"In vitro RetGC activation, CD spectroscopy, protease resistance, and thermal stability assays with recombinant mutants","pmids":["11136713","11484154"],"confidence":"High","gaps":["In vivo confirmation of E155G mechanism needed","P50L mechanism (haploinsufficiency vs. partial constitutive activation) debated"]},{"year":2002,"claim":"Transgenic rescue of GCAP1/GCAP2 double-knockout mice by GCAP1 alone demonstrated that GCAP1 is sufficient for normal rod and cone flash response recovery, establishing its non-redundant physiological role in phototransduction feedback.","evidence":"Transgenic GCAP1 expression in GCAPs double-KO mice; ERG and single-cell recordings","pmids":["11927539","12732716"],"confidence":"High","gaps":["Whether GCAP1 and GCAP2 regulate distinct pools of RetGC remains unresolved","Cone-specific vs rod-specific GCAP1 contributions not fully separated"]},{"year":2006,"claim":"Identifying Mg²⁺-bound GCAP1 (not the apo form) as the true physiological activator of RetGC1 redefined the activator state and assigned specific roles to Mg²⁺ occupancy at EF-hands 2 and 3.","evidence":"In vitro RetGC1 activation at physiological Mg²⁺/Ca²⁺; Trp fluorescence; EF-hand mutagenesis","pmids":["16793776","17545152"],"confidence":"High","gaps":["Structural basis of Mg²⁺-induced activation conformation not resolved at atomic level"]},{"year":2008,"claim":"Cell-based and FRET studies established that EF-hand 2 metal binding is the primary determinant of GCAP1–RetGC1 association (1:1 stoichiometry), while EF-hand 4 solely mediates the activator-to-inhibitor switch, separating binding from regulation.","evidence":"Live-cell co-localization of EF-hand mutants with RetGC1 in HEK293 cells; FRET stoichiometry; mutagenesis of RetGC1 kinase homology domain","pmids":["18541533","20050595"],"confidence":"High","gaps":["No high-resolution structure of the GCAP1–RetGC1 complex"]},{"year":2011,"claim":"Knock-in E155G mice showing progressive cone-dominant degeneration preceded by cGMP accumulation provided the first in vivo proof that constitutive cyclase activation is the pathogenic mechanism in GCAP1-linked cone–rod dystrophy.","evidence":"Gene-targeted knock-in mouse; ERG; retinal histology; cGMP measurements","pmids":["21464903"],"confidence":"High","gaps":["Therapeutic intervention (e.g., PDE6 modulation or gene therapy rescue) not tested","Relative cone vs rod vulnerability mechanism unknown"]},{"year":2014,"claim":"Systematic surface mutagenesis mapped the RetGC1-binding site on GCAP1 to a defined patch spanning EF1–EF3 and identified residues (Met-26, Lys-85, Trp-94) required specifically for cyclase activation beyond binding, distinguishing docking from allosteric stimulation.","evidence":"Comprehensive alanine scanning of GCAP1 surface; co-localization and RetGC1 activation in HEK293 cells and in vitro","pmids":["24567338"],"confidence":"High","gaps":["No direct structural visualization of the GCAP1–RetGC1 interface"]},{"year":2015,"claim":"NMR structure of Mg²⁺-bound GCAP1 revealed that Ca²⁺-dependent structural changes are concentrated in the EF4 'Ca²⁺-switch helix' (residues 164–174), and domain-swap experiments identified the RetGC1 dimerization domain (Arg-822/Met-823) as essential for GCAP binding, completing the structural framework for the regulatory interaction.","evidence":"NMR with residual dipolar couplings; RetGC1/NPRA chimeras; co-localization and in vitro activation assays","pmids":["26703466","26100624"],"confidence":"High","gaps":["No co-structure of the GCAP1–RetGC1 complex","How the switch helix communicates to the cyclase active site is unclear"]},{"year":2018,"claim":"Multiple new disease mutations (E111V, G86R, L176F, N104H) were shown to impair Ca²⁺ sensing through distinct mechanisms—disrupting EF3 coordination, hinge flexibility, or GC affinity—yet all converge on constitutive cyclase activation, consolidating the unified pathogenic model.","evidence":"Recombinant mutant proteins; CD, fluorescence, ITC, limited proteolysis, in vitro RetGC activation assays, and molecular dynamics","pmids":["30184081","30622141","28025326","34639157"],"confidence":"High","gaps":["Genotype-phenotype correlations (cone vs macular dystrophy) not mechanistically explained","Inter-EF-hand allosteric coupling quantitatively unresolved"]},{"year":2020,"claim":"Genetic ablation of GCAPs in rd3 mice substantially delayed photoreceptor death, revealing that Ca²⁺-free GCAP proteins retained in the inner segment cause ER stress and mitochondrial damage—extending the pathogenic role of GCAP1 beyond cGMP toxicity to proteotoxic stress.","evidence":"Double-knockout (rd3 × GCAPs⁻/⁻) mice; ER stress markers; mitochondrial ultrastructure; retinal cell counting","pmids":["31980596"],"confidence":"Medium","gaps":["Relative contribution of GCAP1 vs GCAP2 to ER stress in rd3 not separated","Whether ER stress is upstream or parallel to cGMP-mediated death unclear"]},{"year":2024,"claim":"Direct demonstration that Ca²⁺-loaded GCAP1 binds RD3 (KD ~1.6 µM) to form a ternary inhibitory complex with RetGC1, and that the E111V mutation abolishes this interaction, established RD3-mediated inhibition as a second regulatory axis dependent on GCAP1 conformation.","evidence":"SPR, NMR, AlphaFold3 modeling, enzymatic assays, and immunohistochemistry","pmids":["41819313"],"confidence":"High","gaps":["Cryo-EM or crystal structure of the ternary GCAP1–RD3–RetGC1 complex not available","Physiological significance of GCAP1–RD3 interaction in intact photoreceptors not tested by genetic manipulation"]},{"year":null,"claim":"A high-resolution structure of the GCAP1–RetGC1 complex (and the ternary GCAP1–RD3–RetGC1 complex) is needed to understand how the EF4 Ca²⁺-switch helix communicates allosterically to the cyclase catalytic site, and why different GCAP1 mutations cause cone-dominant versus macular dystrophy phenotypes.","evidence":"","pmids":[],"confidence":"High","gaps":["No co-structure of GCAP1–RetGC1 or GCAP1–RD3–RetGC1 complex","Genotype-phenotype correlations for different GCAP1 mutations mechanistically unexplained","Therapeutic strategies targeting constitutive cyclase activation untested in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,4,5,12,13,19,20]},{"term_id":"GO:0009975","term_label":"cyclase activity","supporting_discovery_ids":[2,3,4]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[3,4,19]}],"localization":[{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[2,25,26]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[25,32]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[2,12,13,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,19,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,5,21,23]}],"complexes":["GCAP1–RetGC1 complex","GCAP1–RD3–RetGC1 ternary complex"],"partners":["GUCY2D","RD3","GUCY2F"],"other_free_text":[]},"mechanistic_narrative":"GUCA1A encodes GCAP1, a myristoylated neuronal calcium sensor that serves as the principal feedback regulator of retinal guanylyl cyclase (RetGC1) in photoreceptor phototransduction. In light-adapted photoreceptors at low Ca²⁺, Mg²⁺ occupancy of EF-hands 2 and 3 drives GCAP1 into an activator conformation that binds RetGC1 through a surface patch on EF1–EF3 and the cyclase dimerization domain, stimulating cGMP synthesis; Ca²⁺ binding to EF-hand 4 during dark adaptation triggers an allosteric conformational switch that converts GCAP1 into a cyclase inhibitor, with additional inhibition mediated by Ca²⁺-dependent binding of RD3 [PMID:16793776, PMID:17545152, PMID:26703466, PMID:41819313]. GCAP1 alone is sufficient to support normal flash response recovery in both rod and cone photoreceptors in vivo [PMID:11927539, PMID:12732716]. Dominant mutations in EF-hand Ca²⁺-coordinating residues (e.g., Y99C, E155G, E111V) impair the Ca²⁺-dependent inhibitory switch, rendering RetGC1 constitutively active and causing toxic cGMP accumulation that leads to autosomal dominant cone and cone–rod dystrophies [PMID:9651312, PMID:11484154, PMID:21464903, PMID:30184081]."},"prefetch_data":{"uniprot":{"accession":"P43080","full_name":"Guanylyl cyclase-activating protein 1","aliases":["Guanylate cyclase activator 1A"],"length_aa":201,"mass_kda":22.9,"function":"Stimulates retinal guanylyl cyclase when free calcium ions concentration is low and inhibits guanylyl cyclase when free calcium ions concentration is elevated (PubMed:18706439, PubMed:19459154, PubMed:30184081, PubMed:30622141). This Ca(2+)-sensitive regulation of retinal guanylyl cyclase is a key event in recovery of the dark state of rod photoreceptors following light exposure (By similarity). May be involved in cone photoreceptor light response and recovery of response in bright light (By similarity)","subcellular_location":"Membrane; Photoreceptor inner segment; Cell projection, cilium, photoreceptor outer segment","url":"https://www.uniprot.org/uniprotkb/P43080/entry"},"depmap":{"release":"DepMap","has_data":false,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GUCA1A"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GUCA1A","total_profiled":1310},"omim":[{"mim_id":"619188","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 64; MRD64","url":"https://www.omim.org/entry/619188"},{"mim_id":"616213","title":"ZINC FINGER PROTEIN 292; ZNF292","url":"https://www.omim.org/entry/616213"},{"mim_id":"605128","title":"GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C","url":"https://www.omim.org/entry/605128"},{"mim_id":"602275","title":"GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B","url":"https://www.omim.org/entry/602275"},{"mim_id":"602093","title":"CONE DYSTROPHY 3; COD3","url":"https://www.omim.org/entry/602093"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Plasma membrane","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":703.2}],"url":"https://www.proteinatlas.org/search/GUCA1A"},"hgnc":{"alias_symbol":["GCAP","GCAP1","COD3","dJ139D8.6","CORD14","GCAP-I","GCAP-1"],"prev_symbol":["GUCA","GUCA1","C6orf131"]},"alphafold":{"accession":"P43080","domains":[{"cath_id":"1.10.238.10","chopping":"13-85","consensus_level":"medium","plddt":74.6027,"start":13,"end":85},{"cath_id":"1.10.238.10","chopping":"87-175","consensus_level":"medium","plddt":76.7283,"start":87,"end":175}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43080","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43080-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43080-F1-predicted_aligned_error_v6.png","plddt_mean":70.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GUCA1A","jax_strain_url":"https://www.jax.org/strain/search?query=GUCA1A"},"sequence":{"accession":"P43080","fasta_url":"https://rest.uniprot.org/uniprotkb/P43080.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43080/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43080"}},"corpus_meta":[{"pmid":"9425234","id":"PMC_9425234","title":"A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9425234","citation_count":194,"is_preprint":false},{"pmid":"9651312","id":"PMC_9651312","title":"Constitutive activation of photoreceptor guanylate cyclase by Y99C mutant of GCAP-1. Possible role in causing human autosomal dominant cone degeneration.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9651312","citation_count":144,"is_preprint":false},{"pmid":"9702199","id":"PMC_9702199","title":"GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9702199","citation_count":125,"is_preprint":false},{"pmid":"9162068","id":"PMC_9162068","title":"Calcium binding, but not a calcium-myristoyl switch, controls the ability of guanylyl cyclase-activating protein GCAP-2 to regulate photoreceptor guanylyl cyclase.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9162068","citation_count":120,"is_preprint":false},{"pmid":"16793776","id":"PMC_16793776","title":"Ca2+ and Mg2+ binding properties of GCAP-1. Evidence that Mg2+-bound form is the physiological activator of photoreceptor guanylyl cyclase.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16793776","citation_count":102,"is_preprint":false},{"pmid":"11927539","id":"PMC_11927539","title":"GCAP1 rescues rod photoreceptor response in GCAP1/GCAP2 knockout mice.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11927539","citation_count":93,"is_preprint":false},{"pmid":"11484154","id":"PMC_11484154","title":"Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11484154","citation_count":92,"is_preprint":false},{"pmid":"15486694","id":"PMC_15486694","title":"Diversity of guanylate cyclase-activating proteins (GCAPs) in teleost fish: characterization of three novel GCAPs (GCAP4, GCAP5, GCAP7) from zebrafish (Danio rerio) and prediction of eight GCAPs (GCAP1-8) in pufferfish (Fugu rubripes).","date":"2004","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15486694","citation_count":85,"is_preprint":false},{"pmid":"19459154","id":"PMC_19459154","title":"Mutations in the GUCA1A gene involved in hereditary cone dystrophies impair calcium-mediated regulation of guanylate cyclase.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19459154","citation_count":69,"is_preprint":false},{"pmid":"15505030","id":"PMC_15505030","title":"A novel mutation (I143NT) in guanylate cyclase-activating protein 1 (GCAP1) associated with autosomal dominant cone degeneration.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15505030","citation_count":67,"is_preprint":false},{"pmid":"10571055","id":"PMC_10571055","title":"Regions in vertebrate photoreceptor guanylyl cyclase ROS-GC1 involved in Ca(2+)-dependent regulation by guanylyl cyclase-activating protein GCAP-1.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10571055","citation_count":67,"is_preprint":false},{"pmid":"7983048","id":"PMC_7983048","title":"Molecular characterization of human and mouse photoreceptor guanylate cyclase-activating protein (GCAP) and chromosomal localization of the human gene.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7983048","citation_count":62,"is_preprint":false},{"pmid":"7589507","id":"PMC_7589507","title":"GCAP-II: isolation and characterization of the circulating form of human uroguanylin.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7589507","citation_count":61,"is_preprint":false},{"pmid":"17545152","id":"PMC_17545152","title":"Activation and inhibition of photoreceptor guanylyl cyclase by guanylyl cyclase activating protein 1 (GCAP-1): the functional role of Mg2+/Ca2+ exchange in EF-hand domains.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17545152","citation_count":61,"is_preprint":false},{"pmid":"20213926","id":"PMC_20213926","title":"Calcium binding, structural stability and guanylate cyclase activation in GCAP1 variants associated with human cone dystrophy.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20213926","citation_count":60,"is_preprint":false},{"pmid":"12732716","id":"PMC_12732716","title":"Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAP1/GCAP2 knockout mice.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12732716","citation_count":59,"is_preprint":false},{"pmid":"15790869","id":"PMC_15790869","title":"A novel GCAP1 missense mutation (L151F) in a large family with autosomal dominant cone-rod dystrophy (adCORD).","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15790869","citation_count":55,"is_preprint":false},{"pmid":"9369488","id":"PMC_9369488","title":"Structural and functional characterization of retinal calcium-dependent guanylate cyclase activator protein (CD-GCAP): identity with S100beta protein.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9369488","citation_count":53,"is_preprint":false},{"pmid":"10391927","id":"PMC_10391927","title":"Conformational changes in guanylyl cyclase-activating protein 1 (GCAP1) and its tryptophan mutants as a function of calcium concentration.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10391927","citation_count":45,"is_preprint":false},{"pmid":"10196158","id":"PMC_10196158","title":"Mapping functional domains of the guanylate cyclase regulator protein, GCAP-2.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10196158","citation_count":44,"is_preprint":false},{"pmid":"16626734","id":"PMC_16626734","title":"The crystal structure of GCAP3 suggests molecular mechanism of GCAP-linked cone dystrophies.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16626734","citation_count":43,"is_preprint":false},{"pmid":"16817789","id":"PMC_16817789","title":"Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils.","date":"2006","source":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16817789","citation_count":43,"is_preprint":false},{"pmid":"8519795","id":"PMC_8519795","title":"A new human guanylate cyclase-activating peptide (GCAP-II, uroguanylin): precursor cDNA and colonic expression.","date":"1995","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8519795","citation_count":42,"is_preprint":false},{"pmid":"18541533","id":"PMC_18541533","title":"Binding of guanylyl cyclase activating protein 1 (GCAP1) to retinal guanylyl cyclase (RetGC1). The role of individual EF-hands.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18541533","citation_count":42,"is_preprint":false},{"pmid":"15953638","id":"PMC_15953638","title":"Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.","date":"2005","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/15953638","citation_count":42,"is_preprint":false},{"pmid":"20370318","id":"PMC_20370318","title":"Involvement of the calcium sensor GCAP1 in hereditary cone dystrophies.","date":"2010","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20370318","citation_count":40,"is_preprint":false},{"pmid":"15452041","id":"PMC_15452041","title":"Cone cell survival and downregulation of GCAP1 protein in the retinas of GC1 knockout mice.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15452041","citation_count":40,"is_preprint":false},{"pmid":"9119368","id":"PMC_9119368","title":"The human GCAP1 and GCAP2 genes are arranged in a tail-to-tail array on the short arm of chromosome 6 (p21.1).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9119368","citation_count":39,"is_preprint":false},{"pmid":"9865963","id":"PMC_9865963","title":"Ca2+-dependent conformational changes in bovine GCAP-2.","date":"1998","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/9865963","citation_count":38,"is_preprint":false},{"pmid":"18706439","id":"PMC_18706439","title":"A novel GCAP1(N104K) mutation in EF-hand 3 (EF3) linked to autosomal dominant cone dystrophy.","date":"2008","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/18706439","citation_count":37,"is_preprint":false},{"pmid":"11136713","id":"PMC_11136713","title":"The destabilization of human GCAP1 by a proline to leucine mutation might cause cone-rod dystrophy.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11136713","citation_count":37,"is_preprint":false},{"pmid":"27739433","id":"PMC_27739433","title":"Allosteric communication pathways routed by Ca2+/Mg2+ exchange in GCAP1 selectively switch target regulation modes.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27739433","citation_count":37,"is_preprint":false},{"pmid":"15735604","id":"PMC_15735604","title":"Autosomal dominant cone dystrophy caused by a novel mutation in the GCAP1 gene (GUCA1A).","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15735604","citation_count":37,"is_preprint":false},{"pmid":"24672427","id":"PMC_24672427","title":"Structural diversity of neuronal calcium sensor proteins and insights for activation of retinal guanylyl cyclase by GCAP1.","date":"2014","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24672427","citation_count":35,"is_preprint":false},{"pmid":"26100624","id":"PMC_26100624","title":"Dimerization Domain of Retinal Membrane Guanylyl Cyclase 1 (RetGC1) Is an Essential Part of Guanylyl Cyclase-activating Protein (GCAP) Binding Interface.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26100624","citation_count":33,"is_preprint":false},{"pmid":"30622141","id":"PMC_30622141","title":"A G86R mutation in the calcium-sensor protein GCAP1 alters regulation of retinal guanylyl cyclase and causes dominant cone-rod degeneration.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30622141","citation_count":32,"is_preprint":false},{"pmid":"8641465","id":"PMC_8641465","title":"Expression of GCAP1 and GCAP2 in the retinal degeneration (rd) mutant chicken retina.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8641465","citation_count":31,"is_preprint":false},{"pmid":"24567338","id":"PMC_24567338","title":"Identification of target binding site in photoreceptor guanylyl cyclase-activating protein 1 (GCAP1).","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24567338","citation_count":31,"is_preprint":false},{"pmid":"28025326","id":"PMC_28025326","title":"Dysfunction of cGMP signalling in photoreceptors by a macular dystrophy-related mutation in the calcium sensor GCAP1.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28025326","citation_count":30,"is_preprint":false},{"pmid":"20238026","id":"PMC_20238026","title":"GCAP1 mutations associated with autosomal dominant cone dystrophy.","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20238026","citation_count":30,"is_preprint":false},{"pmid":"30184081","id":"PMC_30184081","title":"A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30184081","citation_count":29,"is_preprint":false},{"pmid":"24024198","id":"PMC_24024198","title":"Novel GUCA1A mutations suggesting possible mechanisms of pathogenesis in cone, cone-rod, and macular dystrophy patients.","date":"2013","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24024198","citation_count":28,"is_preprint":false},{"pmid":"20050595","id":"PMC_20050595","title":"Activation of retinal guanylyl cyclase RetGC1 by GCAP1: stoichiometry of binding and effect of new LCA-related mutations.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20050595","citation_count":28,"is_preprint":false},{"pmid":"26358777","id":"PMC_26358777","title":"Two retinal dystrophy-associated missense mutations in GUCA1A with distinct molecular properties result in a similar aberrant regulation of the retinal guanylate cyclase.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26358777","citation_count":27,"is_preprint":false},{"pmid":"24352742","id":"PMC_24352742","title":"Disease progression in autosomal dominant cone-rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene.","date":"2013","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/24352742","citation_count":26,"is_preprint":false},{"pmid":"24026978","id":"PMC_24026978","title":"Structural analysis of guanylyl cyclase-activating protein-2 (GCAP-2) homodimer by stable isotope-labeling, chemical cross-linking, and mass spectrometry.","date":"2013","source":"Journal of the American Society for Mass Spectrometry","url":"https://pubmed.ncbi.nlm.nih.gov/24026978","citation_count":26,"is_preprint":false},{"pmid":"28442884","id":"PMC_28442884","title":"Cone dystrophy or macular dystrophy associated with novel autosomal dominant GUCA1A mutations.","date":"2017","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/28442884","citation_count":24,"is_preprint":false},{"pmid":"9439621","id":"PMC_9439621","title":"Differential activation of rod outer segment membrane guanylate cyclases, ROS-GC1 and ROS-GC2, by CD-GCAP and identification of the signaling domain.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9439621","citation_count":24,"is_preprint":false},{"pmid":"26703466","id":"PMC_26703466","title":"Structure of Guanylyl Cyclase Activator Protein 1 (GCAP1) Mutant V77E in a Ca2+-free/Mg2+-bound Activator State.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26703466","citation_count":24,"is_preprint":false},{"pmid":"17936244","id":"PMC_17936244","title":"Characterization of the myristoyl lipid modification of membrane-bound GCAP-2 by 2H solid-state NMR spectroscopy.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17936244","citation_count":24,"is_preprint":false},{"pmid":"11592399","id":"PMC_11592399","title":"Identification of functional regions of guanylate cyclase-activating protein 1 (GCAP1) using GCAP1/GCIP chimeras.","date":"2001","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11592399","citation_count":21,"is_preprint":false},{"pmid":"28125083","id":"PMC_28125083","title":"GUCA1A mutation causes maculopathy in a five-generation family with a wide spectrum of severity.","date":"2017","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28125083","citation_count":21,"is_preprint":false},{"pmid":"24236217","id":"PMC_24236217","title":"Structural insights for activation of retinal guanylate cyclase by GCAP1.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24236217","citation_count":19,"is_preprint":false},{"pmid":"24566882","id":"PMC_24566882","title":"Impact of cone dystrophy-related mutations in GCAP1 on a kinetic model of phototransduction.","date":"2014","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/24566882","citation_count":18,"is_preprint":false},{"pmid":"21464903","id":"PMC_21464903","title":"Dominant cone-rod dystrophy: a mouse model generated by gene targeting of the GCAP1/Guca1a gene.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21464903","citation_count":18,"is_preprint":false},{"pmid":"23472098","id":"PMC_23472098","title":"RNAi-mediated gene suppression in a GCAP1(L151F) cone-rod dystrophy mouse model.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23472098","citation_count":16,"is_preprint":false},{"pmid":"31882816","id":"PMC_31882816","title":"Normal GCAPs partly compensate for altered cGMP signaling in retinal dystrophies associated with mutations in GUCA1A.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31882816","citation_count":16,"is_preprint":false},{"pmid":"15448139","id":"PMC_15448139","title":"Ca(2+)-dependent conformational changes in guanylyl cyclase-activating protein 2 (GCAP-2) revealed by site-specific phosphorylation and partial proteolysis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15448139","citation_count":16,"is_preprint":false},{"pmid":"24778606","id":"PMC_24778606","title":"RNA interference gene therapy in dominant retinitis pigmentosa and cone-rod dystrophy mouse models caused by GCAP1 mutations.","date":"2014","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24778606","citation_count":16,"is_preprint":false},{"pmid":"24875811","id":"PMC_24875811","title":"GUCY2D- or GUCA1A-related autosomal dominant cone-rod dystrophy: is there a phenotypic difference?","date":"2014","source":"Retina (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/24875811","citation_count":15,"is_preprint":false},{"pmid":"23428504","id":"PMC_23428504","title":"Novel GUCA1A mutation identified in a Chinese family with cone-rod dystrophy.","date":"2013","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/23428504","citation_count":14,"is_preprint":false},{"pmid":"32298085","id":"PMC_32298085","title":"Neuronal Calcium Sensor GCAP1 Encoded by GUCA1A Exhibits Heterogeneous Functional Properties in Two Cases of Retinitis Pigmentosa.","date":"2020","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32298085","citation_count":12,"is_preprint":false},{"pmid":"27152249","id":"PMC_27152249","title":"GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy.","date":"2016","source":"Translational vision science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/27152249","citation_count":12,"is_preprint":false},{"pmid":"22371697","id":"PMC_22371697","title":"Interaction of GCAP1 with retinal guanylyl cyclase and calcium: sensitivity to fatty acylation.","date":"2012","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22371697","citation_count":11,"is_preprint":false},{"pmid":"28785759","id":"PMC_28785759","title":"CaF2 nanoparticles as surface carriers of GCAP1, a calcium sensor protein involved in retinal dystrophies.","date":"2017","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/28785759","citation_count":11,"is_preprint":false},{"pmid":"33027977","id":"PMC_33027977","title":"Modulation of Guanylate Cyclase Activating Protein 1 (GCAP1) Dimeric Assembly by Ca2+ or Mg2+: Hints to Understand Protein Activity.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33027977","citation_count":11,"is_preprint":false},{"pmid":"31980596","id":"PMC_31980596","title":"GCAP neuronal calcium sensor proteins mediate photoreceptor cell death in the rd3 mouse model of LCA12 congenital blindness by involving endoplasmic reticulum stress.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31980596","citation_count":10,"is_preprint":false},{"pmid":"20684533","id":"PMC_20684533","title":"Ca(2+) sensor GCAP1: A constitutive element of the ONE-GC-modulated odorant signal transduction pathway.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20684533","citation_count":10,"is_preprint":false},{"pmid":"34639157","id":"PMC_34639157","title":"A Novel GUCA1A Variant Associated with Cone Dystrophy Alters cGMP Signaling in Photoreceptors by Strongly Interacting with and Hyperactivating Retinal Guanylate Cyclase.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34639157","citation_count":10,"is_preprint":false},{"pmid":"31728034","id":"PMC_31728034","title":"Characterization of GUCA1A-associated dominant cone/cone-rod dystrophy: low prevalence among Japanese patients with inherited retinal dystrophies.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31728034","citation_count":9,"is_preprint":false},{"pmid":"30283299","id":"PMC_30283299","title":"Molecular Details of Retinal Guanylyl Cyclase 1/GCAP-2 Interaction.","date":"2018","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30283299","citation_count":8,"is_preprint":false},{"pmid":"32650103","id":"PMC_32650103","title":"Missense mutations affecting Ca2+-coordination in GCAP1 lead to cone-rod dystrophies by altering protein structural and functional properties.","date":"2020","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32650103","citation_count":8,"is_preprint":false},{"pmid":"36157073","id":"PMC_36157073","title":"Structural basis of retinal membrane guanylate cyclase regulation by GCAP1 and RD3.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36157073","citation_count":6,"is_preprint":false},{"pmid":"31979372","id":"PMC_31979372","title":"Constitutive Activation of Guanylate Cyclase by the G86R GCAP1 Variant Is Due to \"Locking\" Cation-π Interactions that Impair the Activator-to-Inhibitor Structural Transition.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31979372","citation_count":6,"is_preprint":false},{"pmid":"16949861","id":"PMC_16949861","title":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.","date":"2006","source":"Hepatology research : the official journal of the Japan Society of Hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/16949861","citation_count":6,"is_preprint":false},{"pmid":"33919796","id":"PMC_33919796","title":"Impaired Ca2+ Sensitivity of a Novel GCAP1 Variant Causes Cone Dystrophy and Leads to Abnormal Synaptic Transmission Between Photoreceptors and Bipolar Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33919796","citation_count":5,"is_preprint":false},{"pmid":"22392341","id":"PMC_22392341","title":"Backbone (1)H, (13)C, and (15)N resonance assignments of guanylyl cyclase activating protein-1, GCAP1.","date":"2012","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/22392341","citation_count":4,"is_preprint":false},{"pmid":"37666794","id":"PMC_37666794","title":"Access to High-Purity 7m G-cap RNA in Substantial Quantities by a Convenient All-Chemical Solid-Phase Method.","date":"2023","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37666794","citation_count":4,"is_preprint":false},{"pmid":"14750595","id":"PMC_14750595","title":"Dominant cone and cone-rod dystrophies: functional analysis of mutations in retGC1 and GCAP1.","date":"2004","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/14750595","citation_count":3,"is_preprint":false},{"pmid":"32025184","id":"PMC_32025184","title":"Functional characterization of a novel GUCA1A missense mutation (D144G) in autosomal dominant cone dystrophy: A novel pathogenic GUCA1A variant in COD.","date":"2019","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/32025184","citation_count":2,"is_preprint":false},{"pmid":"12545196","id":"PMC_12545196","title":"p19 detected in the rat retina and pineal gland is a guanylyl cyclase-activating protein (GCAP).","date":"2002","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/12545196","citation_count":2,"is_preprint":false},{"pmid":"39187109","id":"PMC_39187109","title":"Supramolecular complexes of GCAP1: implications for inherited retinal dystrophies.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39187109","citation_count":1,"is_preprint":false},{"pmid":"12151097","id":"PMC_12151097","title":"Characterisation of two genes for guanylate cyclase activator protein (GCAP1 and GCAP2) in the Japanese pufferfish, Fugu rubripes.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12151097","citation_count":1,"is_preprint":false},{"pmid":"41819313","id":"PMC_41819313","title":"Structural and functional investigation of RD3-GCAP1 interaction in retinal photoreceptors under normal and disease conditions.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41819313","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.11.653351","title":"Isoform-Specific Roles of NTRK2 in Pulmonary Vascular Regeneration","date":"2025-05-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.11.653351","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.11.617840","title":"Radiotherapy triggers pro-angiogenic signaling in human lung","date":"2024-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.11.617840","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44696,"output_tokens":7330,"usd":0.122019},"stage2":{"model":"claude-opus-4-6","input_tokens":11104,"output_tokens":3693,"usd":0.221768},"total_usd":0.343787,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GCAP1 Y99C mutation causes constitutive activation of retinal guanylyl cyclase (RetGC): recombinant Y99C GCAP1 fails to inhibit RetGC even at Ca2+ concentrations above 1 µM, rendering the cyclase constitutively active across the entire physiological Ca2+ range.\",\n      \"method\": \"In vitro reconstitution assay of RetGC activity with recombinant Y99C GCAP1 at varying free Ca2+ concentrations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with recombinant mutant protein; independently replicated in same year by Sokal et al. (PMID:9702199)\",\n      \"pmids\": [\"9651312\", \"9702199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GCAP1 (Y99C) mutant is constitutively active: it persistently stimulates GC1 under physiological dark conditions due to markedly altered Ca2+ sensitivity, consistent with elevated cGMP in dark-adapted cones.\",\n      \"method\": \"In vitro GC1 stimulation assay and Ca2+-dependent activity measurements with recombinant GCAP1(Y99C)\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, replicated across two independent labs\",\n      \"pmids\": [\"9702199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Human GCAP1 (GUCA1A) is a Ca2+-binding protein with three EF-hand motifs expressed exclusively in photoreceptor inner segments, encoded by a four-exon gene localized to chromosome 6p21.1, and stimulates cGMP synthesis.\",\n      \"method\": \"Molecular cloning, in situ hybridization, genomic mapping by somatic hybrid panel and FISH, in vitro cGMP synthesis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods in foundational study; replicated widely\",\n      \"pmids\": [\"7983048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The Mg2+-bound form of GCAP1 (not the cation-free form) is the true physiological activator of RetGC1 in light-adapted photoreceptors; Mg2+ binding in EF-hands 2 and 3 is essential for RetGC1 stimulation.\",\n      \"method\": \"In vitro RetGC1 activation assay at physiological Mg2+/Ca2+ concentrations; tryptophan fluorescence to monitor conformational states; EF-hand mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution + mutagenesis + fluorescence spectroscopy in single rigorous study\",\n      \"pmids\": [\"16793776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mg2+ binding in EF-hand 2 of GCAP1 increases its affinity for RetGC ~40-fold and is essential for cyclase activation; Mg2+ binding in EF-hand 3 enhances stimulation 2-fold; Ca2+ binding in EF-hand 4 triggers the activator-to-inhibitor switch, while EF-hand 3 modulates Ca2+-dependent deceleration indirectly through EF-hand 4.\",\n      \"method\": \"In vitro RetGC1 activation assays with EF-hand mutants; tryptophan fluorescence; Mg2+/Ca2+ competition measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis of all four EF-hands combined with in vitro reconstitution\",\n      \"pmids\": [\"17545152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GCAP1 E155G mutation (in EF4 domain) eliminates Ca2+ binding via loss of bidentate coordination, causing constitutive activation of RetGC at high Ca2+ concentrations and autosomal dominant cone dystrophy.\",\n      \"method\": \"In vitro RetGC activation assay with recombinant E155G GCAP1; structural modeling\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, structural modeling; replicated in later studies\",\n      \"pmids\": [\"11484154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Two short regions (M445–L456 and L503–I522) in the juxtamembrane domain (JMD) of ROS-GC1 are critical for GCAP1-dependent activation, identified by peptide competition and mutagenesis.\",\n      \"method\": \"Peptide competition assays and mutagenesis of ROS-GC1 expressed in cells; in vitro cyclase activity measurements\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis and competition assays define functional domains\",\n      \"pmids\": [\"10571055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Metal binding in EF-hand 2 of GCAP1 is crucial for its binding to RetGC1; EF-hand 3 enhances but is not essential for association; EF-hand 4 mediates only the activator-to-inhibitor switch and is not required for primary cyclase attachment.\",\n      \"method\": \"Co-localization and co-transfection in HEK293 cells with GFP-tagged GCAP1 EF-hand mutants and mOrange-tagged RetGC1; live-cell fluorescence imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-based co-localization with systematic EF-hand mutagenesis; consistent with in vitro data from same lab\",\n      \"pmids\": [\"18541533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RetGC1 binds GCAP1 in an equimolar (1:1) stoichiometry in HEK293 cells; mutations D639Y and R768W in the kinase homology domain of RetGC1 abolish GCAP1 binding and activation, implicating this domain in GCAP1 recognition.\",\n      \"method\": \"FRET-based stoichiometry measurement of fluorescently labeled RetGC1 and GCAP1 co-expressed in HEK293 cells; in vitro reconstitution assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — quantitative stoichiometry in cyto combined with mutagenesis and in vitro activity assay\",\n      \"pmids\": [\"20050595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The RetGC1 binding site on GCAP1 is a distinct surface patch formed by EF-hand 1, the loop and exiting helix of EF-hand 2, and the entering helix of EF-hand 3; residues Met-26, Lys-85, and Trp-94 are required for cyclase activation (an additional step beyond binding).\",\n      \"method\": \"Systematic surface mutagenesis of GCAP1; co-localization and RetGC1 activation assays in HEK293 cells; in vitro RetGC1 stimulation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — comprehensive surface mutagenesis combined with cell-based and in vitro functional assays\",\n      \"pmids\": [\"24567338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The dimerization domain of RetGC1, especially residues Arg-822 and Met-823, is an essential part of the GCAP1/2 binding interface; disruption at this site (R822P, disease mutation) abolishes GCAP binding but not RD3 binding or cyclase dimerization.\",\n      \"method\": \"RetGC1/NPRA chimera construction; co-expression and co-localization assay in HEK293 cells with GFP-tagged GCAP1; in vitro RetGC1 activation assay; functional complementation tests\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic domain-swap mutagenesis with cell-based and in vitro functional validation\",\n      \"pmids\": [\"26100624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NMR structure of GCAP1(V77E) in Ca2+-free/Mg2+-bound activator state reveals that Mg2+ binds at EF2; Ca2+-dependent structural changes occur specifically in the EF4 Ca2+-switch helix (residues 164–174); deletion or mutation of this helix abolishes RetGC1 activation and reduces Ca2+ binding affinity.\",\n      \"method\": \"NMR spectroscopy with residual dipolar coupling; in vitro RetGC1 activation assays; Ca2+ binding analysis of helix deletion mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure combined with functional mutagenesis validation\",\n      \"pmids\": [\"26703466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GCAP1 alone (in the absence of GCAP2) is sufficient to support wild-type flash responses and recovery kinetics in rod photoreceptors in vivo.\",\n      \"method\": \"Transgenic rescue experiment: GCAP1 expressed under endogenous promoter in GCAP1/GCAP2 double-knockout mice; paired-flash ERG recordings; single-cell recordings\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic rescue with electrophysiological functional readout, replicated in subsequent study\",\n      \"pmids\": [\"11927539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GCAP1 is required for normal cone photoreceptor response recovery; GCAP1/GCAP2 double-knockout mice show delayed cone a-wave and b-wave recovery, and transgenic GCAP1 restores normal cone recovery.\",\n      \"method\": \"ERG recordings (photopic, paired-flash) in GCAP null and GCAP1 transgenic rescue mice; immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue with defined electrophysiological phenotype, replicated across labs\",\n      \"pmids\": [\"12732716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GCAP1 P50L mutation reduces protein stability (increased protease susceptibility, reduced thermal stability) without altering Ca2+ sensitivity or RetGC1 activation, suggesting haploinsufficiency via reduced protein concentration as the disease mechanism.\",\n      \"method\": \"In vitro RetGC1 activation assay; circular dichroism spectroscopy; protease resistance assay; thermal stability assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assays with multiple methods, but single lab study\",\n      \"pmids\": [\"11136713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GCAP1 I143NT mutation (in EF4) partially inhibits GC at high Ca2+, adopts a protease-susceptible conformation, and results in incomplete inactivation consistent with constitutive GC activation in dark-adapted cones.\",\n      \"method\": \"In vitro RetGC stimulation assay; fluorescence emission spectra; limited proteolysis; immunoblotting\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — multiple biochemical methods, single lab\",\n      \"pmids\": [\"15505030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Novel GCAP1 mutations (E89K, D100E, G159V, L151F) alter Ca2+-dependent conformational changes and persistent stimulation of guanylate cyclase at physiological Ca2+ concentrations, while still functioning as Ca2+ sensors.\",\n      \"method\": \"Purified recombinant GCAP1 variants; Ca2+-triggered conformational change assays; apparent interaction affinity with RetGC; Ca2+-dependent activation profiles\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization of multiple mutants, single lab\",\n      \"pmids\": [\"19459154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"All tested disease-associated GCAP1 variants (Y99C, E155G, P50L, I143NT) show decreased Ca2+ affinity and reduced thermal stability; myristoylation increases Ca2+ affinity and thermal stability; non-myristoylated mutants activate ROS-GC1 at nonphysiological Ca2+ concentrations.\",\n      \"method\": \"Ca2+ binding measurements; thermal stability assays; ROS-GC1 activation assays; CD spectroscopy\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — multiple biochemical methods, single lab\",\n      \"pmids\": [\"20213926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"N-terminal myristoylation of GCAP1 (Gly2) is required for efficient activation of RetGC1 in vitro; the non-myristoylated G2A mutant co-localizes with RetGC1 less efficiently and shifts Ca2+ sensitivity of the cyclase to higher Ca2+ concentrations.\",\n      \"method\": \"Co-localization of GFP-tagged G2A GCAP1 with RetGC1 in HEK293 cells; in vitro RetGC1 activation assay; Ca2+ binding isotherm measurement\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based co-localization and in vitro reconstitution, single lab\",\n      \"pmids\": [\"22371697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ca2+ binding to GCAP1 causes a major conformational change around the EF3-hand region, transitioning GCAP1 from activator to inhibitor of GC; the Y99C mutation (adjacent to EF3) prevents stabilization of the inactive Ca2+-bound complex; Ca2+ association occurs near diffusion-limit (k1 > 2×10^8 M⁻¹s⁻¹) and dissociation is rapid.\",\n      \"method\": \"Site-directed Trp mutagenesis; fluorescence spectroscopy; stopped-flow kinetics; in vitro GC activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution + spectroscopy + kinetics + mutagenesis in single study\",\n      \"pmids\": [\"10391927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GCAP1 G86R mutation (in the hinge connecting EF-hands 2 and 3) strongly impairs Ca2+-dependent activator-to-inhibitor conformational transition, activates RetGC with higher affinity at low Ca2+ but fails to decelerate it at dark-adapted Ca2+ concentrations; the mutation also reduces sensitivity of RD3-mediated inhibition of the GCAP1-RetGC1 complex.\",\n      \"method\": \"In vitro RetGC1 activation assay; Trp94 fluorescence; isothermal titration calorimetry; dose-response for RD3 inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro methods (ITC, fluorescence, enzyme activity) in single study\",\n      \"pmids\": [\"30622141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Knock-in mice expressing E155G GCAP1 show progressive cone-dominant photoreceptor degeneration preceded by cGMP accumulation, establishing constitutive guanylate cyclase activation as the disease mechanism in dominant cone-rod dystrophy.\",\n      \"method\": \"Gene targeting/knock-in mouse model; ERG; retinal histology; immunohistochemistry; cGMP level measurements\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physiologically relevant knock-in model with multiple functional and molecular readouts\",\n      \"pmids\": [\"21464903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GCAP1 L176F mutation associated with macular dystrophy causes constitutive activation of guanylate cyclase; the mutant is less sensitive to Ca2+ changes, shows 90-fold higher GC activation than WT (vs 20-fold for WT), binds GC with higher apparent affinity, and binds Mg2+ with higher affinity.\",\n      \"method\": \"In vitro RetGC activation assay; Ca2+/Mg2+ binding measurements; CD spectroscopy; molecular dynamics simulations\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization with multiple methods, single lab\",\n      \"pmids\": [\"28025326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GCAP1 E111V mutation disrupts Ca2+ coordination in EF3, reducing Ca2+ affinity ~80-fold; the Mg2+-bound form prone to aggregation; both WT and E111V form dimers; functional assay shows E111V shifts GC inhibition outside physiological Ca2+ range (IC50 ~10 µM), causing constitutive cGMP synthesis.\",\n      \"method\": \"Heterologous expression and purification; circular dichroism; fluorescence spectroscopy; molecular dynamics simulations; in vitro RetGC1 activation assay; analytical gel filtration\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including structural and functional assays in single study\",\n      \"pmids\": [\"30184081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Molecular dynamics simulations reveal that Mg2+/Ca2+ exchange in GCAP1 EF-hands routes allosteric communication pathways that selectively switch GC activation/inhibition; myristoylation mediates long-range allosteric interactions including EF2–EF4 coupling and communication between EF4 and the GC binding interface.\",\n      \"method\": \"Exhaustive molecular dynamics simulations; allosteric pathway analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only, no experimental validation in this study\",\n      \"pmids\": [\"27739433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In GC1 knockout mice, GCAP1 protein is specifically downregulated and absent from photoreceptor outer segments (while GCAP2 is less affected), and GC1-GCAP1 interactions are essential for cone cell function.\",\n      \"method\": \"Western blot; Northern blot; immunohistochemistry of GC1 knockout mouse retina\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with protein localization and expression analysis\",\n      \"pmids\": [\"15452041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GCAP1 is biochemically and physiologically coupled to the olfactory guanylate cyclase ONE-GC in ciliary membranes, where it acts as an incremental stimulator of ONE-GC in response to rising Ca2+ (nanomolar to semi-micromolar range), reversing its inhibitory role in ROS-GC1 phototransduction signaling.\",\n      \"method\": \"Gene deletion; live-cell FRET; surface plasmon resonance spectroscopy; enzyme activity assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — FRET, SPR, and gene deletion with multiple functional readouts, single lab\",\n      \"pmids\": [\"20684533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NMR analysis of GCAP1 reveals that Ca2+-dependent structural changes are concentrated at EF4 and EF1; residues K23 and G32 in EF1 show large chemical shift differences and their mutation decreases RetGC1 activation, confirming a functional conformational change in EF1.\",\n      \"method\": \"NMR chemical shift assignments of Ca2+-saturated WT vs EF4mut GCAP1; site-directed mutagenesis; in vitro RetGC1 activation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — NMR with functional mutagenesis, single study\",\n      \"pmids\": [\"24236217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GCAPs ablation substantially delays photoreceptor cell death in rd3 mice; Ca2+-free GCAP proteins retained at the inner segment in activator conformation induce endoplasmic reticulum stress and mitochondrial swelling, mediating photoreceptor death in LCA12.\",\n      \"method\": \"Genetic double-knockout (rd3 × GCAPs-/-) mice; retinal cell counting; ER stress markers; mitochondrial ultrastructure; phosphorylation state of GCAP2\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with defined cellular phenotype and molecular markers, single study\",\n      \"pmids\": [\"31980596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GCAP1 N104H mutation impairs Ca2+ sensitivity and strongly doubles the affinity for GC (EC50 halved), resulting in constitutive GC hyperactivation; molecular dynamics shows increased flexibility at the GCAP1/GC interface under high Ca2+ conditions.\",\n      \"method\": \"Heterologous expression; circular dichroism; limited proteolysis; dynamic light scattering; in vitro RetGC1 activation assay; molecular dynamics simulations\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization with multiple methods, single lab\",\n      \"pmids\": [\"34639157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RetGC1 undergoes a two-state allosteric switch between active (R-state, stabilized by Ca2+-free/Mg2+-bound GCAP1) and inactive (T-state, stabilized by Ca2+-bound GCAP1 or RD3) conformations; exposed hydrophobic residues H19, Y22, M26, F73, V77, W94 in GCAP1 are essential for cyclase activation.\",\n      \"method\": \"Structural review integrating NMR data, mutagenesis, and modeling\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — review/structural synthesis, not primary experimental data\",\n      \"pmids\": [\"36157073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"D100G, E155A, and E155G mutations in GCAP1 EF-hands cause constitutive GC activation; all three variants form stable dimers with decreased Ca2+ affinity; mutation of bidentate glutamate in one EF-hand allosterically destabilizes the adjacent EF-hand, suggesting inter-EF-hand allosteric coupling.\",\n      \"method\": \"Recombinant protein expression; circular dichroism; fluorescence spectroscopy; in vitro GC activation assay; molecular dynamics simulations\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization with multiple methods, single lab\",\n      \"pmids\": [\"32650103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Wild-type GCAP1 directly interacts with RD3; the interaction is Ca2+-dependent (Ca2+-bound GCAP1 binds RD3 with KD ~1.6 µM, Mg2+-bound GCAP1 much more weakly); the E111V mutation completely abolishes RD3 binding; RD3 inhibits GC1 through dual mechanisms (direct GC1 binding and GCAP1-mediated inhibition); GCAP1-RD3-GC1 co-localize in photoreceptor inner segments and synaptic terminals.\",\n      \"method\": \"Surface plasmon resonance; NMR spectroscopy; AlphaFold3 modeling; enzymatic assays; immunohistochemistry; in vitro reconstitution\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (SPR, NMR, enzyme assays, IHC) in single study with structural validation\",\n      \"pmids\": [\"41819313\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GCAP1 (encoded by GUCA1A) is a myristoylated neuronal Ca2+/Mg2+ sensor protein expressed in photoreceptor outer segments that serves as the principal feedback regulator of retinal guanylyl cyclase (RetGC1): in light-adapted photoreceptors at low Ca2+, its Mg2+-bound form (EF-hands 2 and 3 occupied by Mg2+) binds RetGC1 through a specific surface patch on EF1/EF2/EF3 and the cyclase dimerization domain to stimulate cGMP synthesis; as Ca2+ rises during dark adaptation, Ca2+ binding to EF-hand 4 (the 'Ca2+-switch helix') triggers an allosteric conformational change that converts GCAP1 into a cyclase inhibitor, with additional inhibition mediated by RD3 binding to Ca2+-loaded GCAP1; disease-causing mutations in EF-hands disrupt Ca2+ sensing and render GCAP1 constitutively active, causing toxic cGMP accumulation and dominant cone/cone-rod dystrophies.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GUCA1A encodes GCAP1, a myristoylated neuronal calcium sensor that serves as the principal feedback regulator of retinal guanylyl cyclase (RetGC1) in photoreceptor phototransduction. In light-adapted photoreceptors at low Ca²⁺, Mg²⁺ occupancy of EF-hands 2 and 3 drives GCAP1 into an activator conformation that binds RetGC1 through a surface patch on EF1–EF3 and the cyclase dimerization domain, stimulating cGMP synthesis; Ca²⁺ binding to EF-hand 4 during dark adaptation triggers an allosteric conformational switch that converts GCAP1 into a cyclase inhibitor, with additional inhibition mediated by Ca²⁺-dependent binding of RD3 [PMID:16793776, PMID:17545152, PMID:26703466, PMID:41819313]. GCAP1 alone is sufficient to support normal flash response recovery in both rod and cone photoreceptors in vivo [PMID:11927539, PMID:12732716]. Dominant mutations in EF-hand Ca²⁺-coordinating residues (e.g., Y99C, E155G, E111V) impair the Ca²⁺-dependent inhibitory switch, rendering RetGC1 constitutively active and causing toxic cGMP accumulation that leads to autosomal dominant cone and cone–rod dystrophies [PMID:9651312, PMID:11484154, PMID:21464903, PMID:30184081].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of GCAP1 as a photoreceptor-specific Ca²⁺-binding protein that stimulates cGMP synthesis established the molecular identity of the guanylyl cyclase activating protein in the phototransduction cascade.\",\n      \"evidence\": \"Molecular cloning, in situ hybridization, genomic mapping, and in vitro cGMP synthesis assay\",\n      \"pmids\": [\"7983048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Ca²⁺-dependent regulation not yet defined\", \"Target cyclase identity not confirmed in vivo\", \"Role of individual EF-hands unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that the Y99C disease mutation renders GCAP1 constitutively active across the full Ca²⁺ range linked a specific molecular defect—loss of Ca²⁺-dependent inhibition—to dominant cone dystrophy and established the activator-to-inhibitor switch as essential for photoreceptor health.\",\n      \"evidence\": \"In vitro RetGC reconstitution assays with recombinant Y99C GCAP1 at varying Ca²⁺, replicated independently by two labs\",\n      \"pmids\": [\"9651312\", \"9702199\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Y99C effect unknown\", \"In vivo consequences not yet demonstrated in animal model\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Fluorescence and kinetic analyses revealed that Ca²⁺ binding triggers a major conformational change near EF3, transitioning GCAP1 from activator to inhibitor, and that the Y99C mutation prevents this transition—establishing the conformational switch mechanism.\",\n      \"evidence\": \"Site-directed Trp mutagenesis, fluorescence spectroscopy, stopped-flow kinetics, and in vitro GC assays\",\n      \"pmids\": [\"10391927\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of activator vs inhibitor states not available\", \"Role of Mg²⁺ not yet appreciated\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping two short regions in the RetGC1 juxtamembrane domain as critical for GCAP1-dependent activation began defining the cyclase-side binding interface.\",\n      \"evidence\": \"Peptide competition and mutagenesis of ROS-GC1 with in vitro cyclase activity readout\",\n      \"pmids\": [\"10571055\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full binding interface on both partners undefined\", \"Stoichiometry unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Characterization of P50L (haploinsufficiency via protein instability) and E155G (constitutive activation via loss of EF4 Ca²⁺ coordination) established that distinct molecular mechanisms—both affecting Ca²⁺-dependent regulation—underlie different GCAP1 disease alleles.\",\n      \"evidence\": \"In vitro RetGC activation, CD spectroscopy, protease resistance, and thermal stability assays with recombinant mutants\",\n      \"pmids\": [\"11136713\", \"11484154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation of E155G mechanism needed\", \"P50L mechanism (haploinsufficiency vs. partial constitutive activation) debated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Transgenic rescue of GCAP1/GCAP2 double-knockout mice by GCAP1 alone demonstrated that GCAP1 is sufficient for normal rod and cone flash response recovery, establishing its non-redundant physiological role in phototransduction feedback.\",\n      \"evidence\": \"Transgenic GCAP1 expression in GCAPs double-KO mice; ERG and single-cell recordings\",\n      \"pmids\": [\"11927539\", \"12732716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GCAP1 and GCAP2 regulate distinct pools of RetGC remains unresolved\", \"Cone-specific vs rod-specific GCAP1 contributions not fully separated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying Mg²⁺-bound GCAP1 (not the apo form) as the true physiological activator of RetGC1 redefined the activator state and assigned specific roles to Mg²⁺ occupancy at EF-hands 2 and 3.\",\n      \"evidence\": \"In vitro RetGC1 activation at physiological Mg²⁺/Ca²⁺; Trp fluorescence; EF-hand mutagenesis\",\n      \"pmids\": [\"16793776\", \"17545152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Mg²⁺-induced activation conformation not resolved at atomic level\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Cell-based and FRET studies established that EF-hand 2 metal binding is the primary determinant of GCAP1–RetGC1 association (1:1 stoichiometry), while EF-hand 4 solely mediates the activator-to-inhibitor switch, separating binding from regulation.\",\n      \"evidence\": \"Live-cell co-localization of EF-hand mutants with RetGC1 in HEK293 cells; FRET stoichiometry; mutagenesis of RetGC1 kinase homology domain\",\n      \"pmids\": [\"18541533\", \"20050595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the GCAP1–RetGC1 complex\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Knock-in E155G mice showing progressive cone-dominant degeneration preceded by cGMP accumulation provided the first in vivo proof that constitutive cyclase activation is the pathogenic mechanism in GCAP1-linked cone–rod dystrophy.\",\n      \"evidence\": \"Gene-targeted knock-in mouse; ERG; retinal histology; cGMP measurements\",\n      \"pmids\": [\"21464903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic intervention (e.g., PDE6 modulation or gene therapy rescue) not tested\", \"Relative cone vs rod vulnerability mechanism unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Systematic surface mutagenesis mapped the RetGC1-binding site on GCAP1 to a defined patch spanning EF1–EF3 and identified residues (Met-26, Lys-85, Trp-94) required specifically for cyclase activation beyond binding, distinguishing docking from allosteric stimulation.\",\n      \"evidence\": \"Comprehensive alanine scanning of GCAP1 surface; co-localization and RetGC1 activation in HEK293 cells and in vitro\",\n      \"pmids\": [\"24567338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct structural visualization of the GCAP1–RetGC1 interface\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"NMR structure of Mg²⁺-bound GCAP1 revealed that Ca²⁺-dependent structural changes are concentrated in the EF4 'Ca²⁺-switch helix' (residues 164–174), and domain-swap experiments identified the RetGC1 dimerization domain (Arg-822/Met-823) as essential for GCAP binding, completing the structural framework for the regulatory interaction.\",\n      \"evidence\": \"NMR with residual dipolar couplings; RetGC1/NPRA chimeras; co-localization and in vitro activation assays\",\n      \"pmids\": [\"26703466\", \"26100624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-structure of the GCAP1–RetGC1 complex\", \"How the switch helix communicates to the cyclase active site is unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Multiple new disease mutations (E111V, G86R, L176F, N104H) were shown to impair Ca²⁺ sensing through distinct mechanisms—disrupting EF3 coordination, hinge flexibility, or GC affinity—yet all converge on constitutive cyclase activation, consolidating the unified pathogenic model.\",\n      \"evidence\": \"Recombinant mutant proteins; CD, fluorescence, ITC, limited proteolysis, in vitro RetGC activation assays, and molecular dynamics\",\n      \"pmids\": [\"30184081\", \"30622141\", \"28025326\", \"34639157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlations (cone vs macular dystrophy) not mechanistically explained\", \"Inter-EF-hand allosteric coupling quantitatively unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Genetic ablation of GCAPs in rd3 mice substantially delayed photoreceptor death, revealing that Ca²⁺-free GCAP proteins retained in the inner segment cause ER stress and mitochondrial damage—extending the pathogenic role of GCAP1 beyond cGMP toxicity to proteotoxic stress.\",\n      \"evidence\": \"Double-knockout (rd3 × GCAPs⁻/⁻) mice; ER stress markers; mitochondrial ultrastructure; retinal cell counting\",\n      \"pmids\": [\"31980596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of GCAP1 vs GCAP2 to ER stress in rd3 not separated\", \"Whether ER stress is upstream or parallel to cGMP-mediated death unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Direct demonstration that Ca²⁺-loaded GCAP1 binds RD3 (KD ~1.6 µM) to form a ternary inhibitory complex with RetGC1, and that the E111V mutation abolishes this interaction, established RD3-mediated inhibition as a second regulatory axis dependent on GCAP1 conformation.\",\n      \"evidence\": \"SPR, NMR, AlphaFold3 modeling, enzymatic assays, and immunohistochemistry\",\n      \"pmids\": [\"41819313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cryo-EM or crystal structure of the ternary GCAP1–RD3–RetGC1 complex not available\", \"Physiological significance of GCAP1–RD3 interaction in intact photoreceptors not tested by genetic manipulation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the GCAP1–RetGC1 complex (and the ternary GCAP1–RD3–RetGC1 complex) is needed to understand how the EF4 Ca²⁺-switch helix communicates allosterically to the cyclase catalytic site, and why different GCAP1 mutations cause cone-dominant versus macular dystrophy phenotypes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-structure of GCAP1–RetGC1 or GCAP1–RD3–RetGC1 complex\", \"Genotype-phenotype correlations for different GCAP1 mutations mechanistically unexplained\", \"Therapeutic strategies targeting constitutive cyclase activation untested in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 12, 13, 19, 20]},\n      {\"term_id\": \"GO:0009975\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [3, 4, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [2, 25, 26]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [25, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [2, 12, 13, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 19, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 5, 21, 23]}\n    ],\n    \"complexes\": [\n      \"GCAP1–RetGC1 complex\",\n      \"GCAP1–RD3–RetGC1 ternary complex\"\n    ],\n    \"partners\": [\n      \"GUCY2D\",\n      \"RD3\",\n      \"GUCY2F\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}